“For Cause” Inspections Find Galloping Clinical Trial Violation Rate
This article was originally published in The Gray Sheet
Executive Summary
The violation rate for clinical trial sponsors shot up in fiscal year 2007, hitting a 10-year high, with FDA finding many of the problems during inspections triggered by complaints, according to CDRH
You may also be interested in...
Sponsors Rein In Clinical Trial Violation Rate, But Monitoring Is Problematic
Despite improvements in sponsors' compliance with clinical trial regulations last year, trial monitoring continues to be an issue, according to CDRH
Sponsors Rein In Clinical Trial Violation Rate, But Monitoring Is Problematic
Despite improvements in sponsors' compliance with clinical trial regulations last year, trial monitoring continues to be an issue, according to CDRH
FDA Spells Out Details Of Premarket Clinical Trial Inspections
A final guidance document released by FDA Jan. 8 gives the timetable that device makers can expect when PMA applications and supplements are reviewed by the device center's bioresearch monitoring division